Sensus Healthcare, Inc.SRTSNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +126.76% | +3.98% | -21.75% | -20.82% | -22.12% |
| Gross Profit Growth | +163.45% | -9.23% | -34.64% | -46.47% | -48.23% |
| EBITDA Growth | +0.00% | -68.53% | -183.23% | -186.65% | -61.05% |
| Operating Income Growth | +0.00% | -69.05% | -191.65% | -198.03% | -271.84% |
| Net Income Growth | +0.00% | -63.28% | -213.10% | -164.33% | -177.61% |
| EPS Growth | +0.00% | -63.62% | -214.29% | -164.21% | -177.69% |
| EPS Diluted Growth | +0.00% | -63.85% | -214.29% | -164.34% | -176.04% |
| Weighted Average Shares Growth | +0.31% | +0.39% | +0.11% | +0.13% | +0.04% |
| Weighted Average Shares Diluted Growth | +0.46% | +1.04% | +0.25% | -0.08% | -0.11% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +794.34% | -131.00% | +0.00% | -26.31% | -100.00% |
| Free Cash Flow Growth | +738.98% | -119.87% | +0.00% | -26.90% | -100.00% |
| Receivables Growth | +146.42% | +85.35% | -8.19% | -31.00% | -44.96% |
| Inventory Growth | -9.35% | +13.35% | -32.59% | -2.85% | +20.16% |
| Asset Growth | +18.42% | +15.74% | +5.13% | +1.18% | -2.61% |
| Book Value per Share Growth | +21.03% | +13.86% | +3.46% | -1.71% | -5.46% |
| Debt Growth | -21.66% | -23.12% | -12.10% | -14.76% | -17.97% |
| R&D Expense Growth | -20.31% | +130.24% | +181.43% | +69.86% | +110.78% |
| SG&A Expenses Growth | +2.89% | +142.63% | +54.23% | +31.07% | +20.16% |